Evaluation the -۱۷۴G>C Genetic Polymorphism of Interleukin-۶ in Iranian Patients with Chronic Lymphocytic Leukemia
محل انتشار: فصلنامه آسیب شناسی ایران، دوره: 18، شماره: 4
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 146
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-18-4_002
تاریخ نمایه سازی: 23 آبان 1402
چکیده مقاله:
Background & Objective: Interleukin-۶ (IL-۶) is involved in inflammation and has a significant role in chronic lymphocytic leukemia (CLL) progression. Accordingly, IL-۶ level may increase in CLL-affected patients compared to healthy individuals. The -۱۷۴G>C single nucleotide polymorphism (SNP) in IL-۶ promoter region has been related to differences in IL-۶ transcription. Therefore, we investigated the possible association of IL-۶ polymorphism with CLL.Methods: We examined the -۱۷۴G>C SNP in IL-۶ gene and studied its possible relationship with CLL in affected patients and in healthy controls using Amplification Refractory Mutation System- polymerase chain reaction genotyping method. IL-۶ plasma level was measured in both studied groups.Results: According to the results, IL-۶ mean plasma concentration was increased significantly in the CLL patients compared to the controls. However, ۱۷۴G>C genotype of the IL-۶ gene was not associated with CLL. Furthermore, there were no significant differences in the distribution of allele and genotype frequencies between the CLL-affected patients and the controls (P>۰.۰۵).Conclusion: Our study showed that -۱۷۴G>C SNP in promotor of IL-۶ gene could not be considered a risk factor for CLL. Larger prospective studies should be performed to confirm our results.
کلیدواژه ها:
نویسندگان
Zakieh Rostamzadeh Khameneh
Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran
Mahshid Mohammadian
Department of Clinical Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
Ali Eishi Oskuie
Department of Hematology and Medical Oncology, Urmia University of Medical Sciences, Urmia, Iran
Rahim Asghari
Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
Mohadeseh Nemati
Department of Clinical Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :